Question follow-through · 115869
British Business Bank
To ask the Secretary of State for Business and Trade, what steps his Department is taking to ensure the British Business Bank supports stocks traded on AIM and Aquis.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department for Business and Trade
- Tabled
- 25 Feb 2026
- Target answer date
- 2 Mar 2026
- Answer
- 2 Mar 2026 · 5 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
Votes on this topic
- Draft Code of Practice on Electronic and Workplace Ballots for Statutory Trade Union Ballots · 15 Jul 2026
- Draft Trade Unions (Permissible Means of Voting) and Employment Rights (Unfair Dismissal) (Amendment) Order 2026 · 15 Jul 2026
- Taxation (Energy and Vehicles) Bill Committee: New Clause 5 · 1 Jul 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
25 Feb 2026
Question tabled
To ask the Secretary of State for Business and Trade, what steps his Department is taking to ensure the British Business Bank supports stocks traded on AIM and Aquis.
2 Mar 2026
Target answer date
Date supplied by the official written-questions record.
2 Mar 2026
Answer published
The British Business Bank’s mission is to drive economic growth by helping smaller businesses get the finance they need to start, scale and stay in the UK.Through its equity and debt programmes, the Bank supports privately held businesses in the earlier s...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
No later same-department questions indexed.
This is an absence in covered public data, not evidence that no follow-up occurred elsewhere.